Application 761315

Type
BLA
Sponsor
NOVO NORDISK INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ALHEMOCONCIZUMAB-MTCIInjectable; Subcutaneous60MG/1.5ML(40MG/ML)NoNo
002ALHEMOCONCIZUMAB-MTCIInjectable; Subcutaneous150MG/1.5ML(100MG/ML)NoNo
003ALHEMOCONCIZUMAB-MTCIInjectable; Subcutaneous300MG/3ML(100MG/ML)NoNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
83030SUPPL 2025-08-01
83029SUPPL 2025-08-01
83021SUPPL 2025-08-01
82261SUPPL 2025-05-02
80919ORIG 2025-02-05
80745ORIG 2024-12-27
80676ORIG 2024-12-20